ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,081Medicare Part D Prescriptions Filled, Including Refills

Rank: 80 out of 617

$631K Total Retail Price of All Prescriptions

Rank: 40 out of 617

466 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 466 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 466 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,629 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
FUROSEMIDE 363 324 1 4
WARFARIN SODIUM 336 302 2 7
LEVOTHYROXINE SODIUM 329 310 3 1
SIMVASTATIN 329 307 3 2
AMLODIPINE BESYLATE 322 317 5 6
OMEPRAZOLE 315 257 6 3
POTASSIUM CHLORIDE 289 261 7 10
LISINOPRIL 250 232 8 5
ATENOLOL 213 192 9 17
HYDROCODONE-ACETAMINOPHEN 212 180 S3 10 8
METFORMIN HCL 208 190 11 9
METOPROLOL TARTRATE 202 201 12 11
PREDNISONE 195 181 13 31
PRAVASTATIN SODIUM 177 177 14 21
DIOVAN 142 131 15 41
TAMSULOSIN HCL 142 129 15 26
TRAMADOL HCL 142 139 15 15
GLIMEPIRIDE 138 136 18 33
SPIRONOLACTONE 135 122 19 42
CARVEDILOL 132 126 20 19
GABAPENTIN 130 121 21 16
MIRTAZAPINE 118 118 22 50
DONEPEZIL HCL 113 113 23 30
METOPROLOL SUCCINATE 106 92 24 12
CYMBALTA 103 85 25 49
LANTUS 102 91 26 39
ALLOPURINOL 97 97 27 27
CITALOPRAM HBR 95 95 28 18
POLYETHYLENE GLYCOL 3350 94 89 29 32
NAMENDA 93 93 30 35
SPIRIVA 92 52 31 61
HYDROCHLOROTHIAZIDE 90 90 32 13
VENLAFAXINE HCL ER 81 71 33 76
ENALAPRIL MALEATE 80 80 34 34
LEVOFLOXACIN 80 72 34 89
ATORVASTATIN CALCIUM 79 66 36 14
CLONIDINE HCL 76 76 37 55
BENAZEPRIL HCL 72 72 38 44
DIGOXIN 72 62 38 48
RANITIDINE HCL 67 25 40 40
PROAIR HFA 66 49 41 75
BYSTOLIC 66 59 41 64
NEXIUM 66 45 41 43
LOSARTAN POTASSIUM 65 56 44 22
OXYCONTIN 65 23 S2 44 133
SERTRALINE HCL 63 63 46 20
VERAPAMIL ER 63 42 46 90
DIOVAN HCT 63 63 46 97
EXFORGE 62 62 49 193
ALENDRONATE SODIUM 61 44 50 25
AMLODIPINE BESYLATE-BENAZEPRIL 59 47 51 80
MUPIROCIN 57 41 52 176
ADVAIR DISKUS 56 56 53 38
PROPRANOLOL HCL 56 56 53 109
ZOLPIDEM TARTRATE 55 52 55 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 41 56 29
HYDRALAZINE HCL 51 51 57 164
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.